LIGAND PHARMACEUTICALS INCORPORATED Gain (Loss) on Sale of Derivatives
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Gain (Loss) on Sale of Derivatives of $300.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2024-02-29
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on sale of derivatives for fiscal 2023 was $300.00K.
| Period end | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|
| 2023-12-31 | $300.00K 10-K · filed 2024-02-29 |